Literature DB >> 35316991

Pyoderma gangrenosum induced by transcutaneous electrical nerve stimulation: a case report with literature review.

Diana Isabela Costescu Strachinaru1, Axel De Greef2, Liliane Marot2, Valérie Lerate3, Marie-Sophie Paridaens3.   

Abstract

Pyoderma gangrenosum (PG) is one of the neutrophilic dermatosis, a heterogenous group of rare inflammatory diseases affecting the skin. It is often associated with systemic diseases such as inflammatory bowel disease, rheumatoid arthritis or hematological malignancies. Classical PG is characterized by painful ulcers with violaceous, undermined border, often developing at sites of injury because of the typical pathergy phenomenon. Because of its polymorphic presentation, misdiagnosis and delayed diagnosis are common. We present a case of PG occurring after transcutaneous electrical nerve stimulation (TENS) in a young female patient with ulcerative colitis. Although electric current has previously been incriminated as a trigger for PG, to the best of our knowledge this is the first case precipitated by TENS. We report a typical case of PG occurring after an unusual stimulus and highlight the challenges that the diagnosis of this relatively rare pathology poses to the clinician.
© The Author(s) 2022. Published by Oxford University Press.

Entities:  

Year:  2022        PMID: 35316991      PMCID: PMC8931814          DOI: 10.1093/omcr/omac017

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


INTRODUCTION

Pyoderma gangrenosum (PG) is a neutrophilic dermatosis, a rare inflammatory disease affecting the skin [1]. There are several types of PG, including classical (ulcerative), bullous, pustular, granulomatous superficial (vegetative), peristomal and post-surgical [2, 3]. The classical form is the most frequent presentation and occurs mainly on the lower extremities [1-3]. Classical PG is characterized by the development of sterile inflammatory pustules, which expand into painful ulcers with violaceous, undermined borders [1-3]. PG may occur in the absence of an underlying pathology, but in up to two-thirds of cases it is associated with systemic diseases such as inflammatory bowel disease (IBD), rheumatoid arthritis or hematological malignancies [1-3]. IBD is the most common comorbidity in younger PG patients [1, 4]. PG occurs in ~1–2% of IBD patients [4]. Herein, we report a case of PG occurring after transcutaneous electrical nerve stimulation (TENS) in a patient with ulcerative colitis (UC).

CASE REPORT

A 27-year-old woman was referred to our Burn Unit for the management of painful, progressive ulcers located on her legs. She had presented bilateral ankle tendinopathy 5 weeks earlier, for which she underwent TENS sessions (mild electrical currents were administered using electrode pads placed on the skin surface of the lateral and medial sides of both ankles). Following the fifth session, bluish-mauve swellings appeared on the left lateral and medial malleoli and on the right lateral malleolus, which ulcerated and extended despite topical cortisone. She reported no fever or systemic symptoms. Daily local bactericidal dressing and successive antibiotic therapies with amoxicillin-clavulanic acid, cefuroxime and piperacillin-tazobactam resulted in the pejoration of the lesions. A computed-tomography scan of the ankles revealed infiltration of the subcutaneous tissue but no bone damage. As there was no improvement, she was referred to our institution with a diagnosis of infected electric burns. Detailed anamnesis revealed a 12-year-old history of UC, stable under mesalazine, not mentioned earlier. Physical examination on admission showed a large purplish ulcer of 16/7 cm, situated on the left lateral malleolus and two smaller ulcers on the left medial and right lateral malleoli (Fig. 1A–C). The rest of the examination was unremarkable. Biology tests were normal except for moderate normocytic hypochromic anemia and a C reactive protein value of 52.8 mg/l (normal range 0–5 mg/l). Immunological (rheumatoid factor, antineutrophil cytoplasmic antibodies, antinuclear antibodies and HLA B27), serological tests (hepatitis B and C, human immunodeficiency virus, syphilis, Rickettsia and Leishmania), bacterial and fungal wound swabs and blood cultures were negative. Skin biopsies revealed a dense polymorphic inflammatory dermal infiltrate, very rich in neutrophils, with a site of deep abscedation, compatible with PG (Fig. 2A and B). Special stains (Periodic Acid Schiff, Wade-Fite, Ziehl-Neelsen and Gram) were negative for bacteria, fungi and mycobacteria. Immunosuppressive treatment with high dose oral methylprednisolone (1 mg/kg/day) followed by the addition of ciclosporin 1 month later, when steroid tapering began, combined with topical tacrolimus and adjunctive hyperbaric oxygen therapy resulted in a favorable evolution, with complete resolution of the lesions and characteristic cribriform scars at 3.5 months (Fig. 1D–F).
Figure 1

Panels A–C: aspect of the wounds at referral to our Burn Unit (Panel A: left leg, lateral malleolus, Panel B: left leg, medial malleolus, Panel C: right leg, lateral malleolus). Panels D–F: follow-up at 3.5 months of treatment (Panel D: left leg, lateral malleolus, Panel E: left leg, medial malleolus Panel F: right leg, lateral malleolus).

Figure 2

Hematoxylin–eosin stain, showing a dense polymorphic inflammatory dermal infiltrate, very rich in neutrophils (Panel A: ×3,46 magnification, Panel B: ×20 magnification).

Panels A–C: aspect of the wounds at referral to our Burn Unit (Panel A: left leg, lateral malleolus, Panel B: left leg, medial malleolus, Panel C: right leg, lateral malleolus). Panels D–F: follow-up at 3.5 months of treatment (Panel D: left leg, lateral malleolus, Panel E: left leg, medial malleolus Panel F: right leg, lateral malleolus). Hematoxylin–eosin stain, showing a dense polymorphic inflammatory dermal infiltrate, very rich in neutrophils (Panel A: ×3,46 magnification, Panel B: ×20 magnification).

DISCUSSION

PG is the second most frequent dermatologic manifestation of IBD [4, 5]. It occurs mainly when the IBD is active but can also manifest during quiescent periods or precede the IBD diagnosis [4, 5]. Because of its polymorphic presentation, frequent association with various systemic diseases and ability to imitate other conditions, misdiagnosis or delayed diagnosis are common in PG [6, 7]. In our patient, lesions mimicked infected burn wounds, leading to misdiagnosis, inappropriate treatment and clinical deterioration. This case highlights the diagnostic challenges posed by PG and the importance of thorough patient anamnesis, as the patient’s UC history first raised the suspicion of PG. To this day, PG remains mainly a clinical diagnosis. Skin biopsies are recommended to exclude other causes of cutaneous ulceration. The histopathology of PG typically shows neutrophilic inflammation, but it is nonspecific (infections and other neutrophilic dermatosis may have similar findings) and can vary based on PG subtype, ulcer stage, timing and site of biopsy [7]. To date there is no consensus regarding the diagnosis of PG. Su et al. proposed in 2004 a diagnostic tool for classical PG requiring two major and two minor criteria [8], but in this algorithm PG remains an exclusion diagnosis, which can be impractical for clinical decision. In 2018, Maverakis et al. proposed new criteria based on the Delphi Consensus of International Experts, requiring one major and four minor criteria, and no longer rendering PG as a diagnosis of exclusion [7]. More recently, Jockenhöfer et al. developed another diagnostic tool, the PARACELSUS score [9]. Our patient met diagnostic criteria with each of the three above-mentioned scores. There is no standardized treatment of PG [2-4]. Topical treatment with steroids or calcineurin inhibitors may be tried in mild forms or those not associated with systemic disease. For systemic treatment, corticosteroids are first-line [2-4]. Corticosteroids may be combined with immunomodulatory agents such as cyclosporine, methotrexate, mycophenolate mofetil or azathioprine. Biologic therapies such as tumor necrosis factor-α inhibitors or interleukin 1 inhibitors have been increasingly proposed in recent years [2-4]. In addition, analgesia and wound care are two cornerstones of PG management. Hyperbaric oxygen therapy can be a helpful adjuvant. PG lesions may be precipitated by minor traumas, a phenomenon known as ‘pathergy’. Because of this phenomenon, surgery is not recommended as it may worsen the lesions and delay the healing [4]. Although electric current has previously been incriminated as a trigger for PG lesions—Ichikawa et al. described PG lesions appearing at the site of the grounding pad of an electric scalpel [10]—this is, to the best of our knowledge, the first reported case of PG precipitated by TENS. We hypothesize that in this case the lesions were triggered by the electrical stimulus in a patient in which the underlying UC put her at a higher risk of developing PG. In conclusion, we present a typical case of PG occurring after an unusual stimulus, while also highlighting the challenges that the diagnosis and management of this relatively rare pathology pose to the clinician.
  10 in total

1.  Pyoderma gangrenosum reproduced by an electric current flow.

Authors:  Ayaka Ichikawa; Makoto Kondo; Keiichi Yamanaka
Journal:  J Dermatol       Date:  2018-07-16       Impact factor: 4.005

Review 2.  Skin ulcers misdiagnosed as pyoderma gangrenosum.

Authors:  Roger H Weenig; Mark D P Davis; Patrick R Dahl; W P Daniel Su
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

Review 3.  Pyoderma Gangrenosum: A Review for the Gastroenterologist.

Authors:  Isabella Plumptre; Daniel Knabel; Kenneth Tomecki
Journal:  Inflamm Bowel Dis       Date:  2018-11-29       Impact factor: 5.325

4.  Pyoderma gangrenosum - a guide to diagnosis and management .

Authors:  Christina George; Florence Deroide; Malcolm Rustin
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

Review 5.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.

Authors:  W P Daniel Su; Mark D P Davis; Roger H Weenig; Frank C Powell; Harold O Perry
Journal:  Int J Dermatol       Date:  2004-11       Impact factor: 2.736

6.  Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

Authors:  Emanual Maverakis; Chelsea Ma; Kanade Shinkai; David Fiorentino; Jeffrey P Callen; Uwe Wollina; Angelo Valerio Marzano; Daniel Wallach; Kyoungmi Kim; Courtney Schadt; Anthony Ormerod; Maxwell A Fung; Andrea Steel; Forum Patel; Rosie Qin; Fiona Craig; Hywel C Williams; Frank Powell; Alexander Merleev; Michelle Y Cheng
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

7.  The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.

Authors:  Hovik J Ashchyan; Daniel C Butler; Caroline A Nelson; Megan H Noe; William G Tsiaras; Stephen J Lockwood; William D James; Robert G Micheletti; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

8.  The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum.

Authors:  F Jockenhöfer; U Wollina; K A Salva; S Benson; J Dissemond
Journal:  Br J Dermatol       Date:  2018-05-06       Impact factor: 9.302

Review 9.  Dermatological Manifestations in Inflammatory Bowel Diseases.

Authors:  Elisabetta Antonelli; Gabrio Bassotti; Marta Tramontana; Katharina Hansel; Luca Stingeni; Sandro Ardizzone; Giovanni Genovese; Angelo Valerio Marzano; Giovanni Maconi
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

Review 10.  Recent advances in managing and understanding pyoderma gangrenosum.

Authors:  Josh Fletcher; Raed Alhusayen; Afsaneh Alavi
Journal:  F1000Res       Date:  2019-12-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.